May 25 2015
- Orthocell presents as invited speakers its clinical data and pipeline opportunities at the World Stem Cell and Regenerative Medicine Congress in London
- Paper entitled Cells, Scaffolds and Bioreactors for the Regeneration of Human Tendons well received
- Generation of human tendon outside the body a key technology breakthrough
Regenerative medicine company Orthocell Limited is pleased to announce it presented as invited speakers a paper entitled Cells, Scaffolds and Bioreactors for the Regeneration of Human Tendons at the World Stem Cells and Regenerative Medicine Congress, a leading international regenerative medicine conference, in London.
Orthocell’s current and future approaches to the regeneration of tendon tissue were presented with particular focus on the recent breakthrough by the Company in demonstrating its new technology to grow human tendons outside of the body (OCC announcement First Human Tendons Grown in Laboratory, Nov 6, 2014). Orthocell also presented the recently published successful 4.5 year follow up of its Ortho-ATI™ injection for regeneration of degenerate tendons.
Orthocell Managing Director Mr. Paul Anderson said: “As invited speakers at a significant global forum, we continue to demonstrate the world-leading character of our tendon regeneration work and the significant commercial interest in our mobility enhancing therapies.
The breakthrough of growing functioning and healthy tendon outside the body was well received and positions Orthocell as one of the leading global companies in the musculoskeletal regenerative space
The conference was attended by leading researchers, clinicians, companies and financiers and is held annually in London.
Mr Anderson said:
This is the second time we have been invited to present at the conference and it is a pleasure to return with more positive clinical data, groundbreaking tissue engineering approaches and significant milestones achieved
Source: Orthocell
Beer consumption alters red blood cell lipid composition